Selected Publications
For a complete list check at : ORCID or at: pubmed
| Year | Publication |
|---|---|
| 2024 | Ramesh J, Gopalakrishnan RM, Nguyen THA, Lai SK, Li HY, Kim PS, Kutzner A, Inoue N, Heese K. Deciphering the molecular landscape of the FAM72 gene family: Implications for stem cell biology and cancer. Neurochem Int. 180: 105853 (2024). (pdf) |
| 2024 | Pramanik S, Devi MH, Chakrabarty S, Paylar B, Pradhan A, Thaker M, Ayyadhury S, Manavalan A, Olsson PE, Pramanik G, Heese K. Microglia signaling in health and disease – Implications in sex-specific brain development and plasticity. Neurosci Biobehav Rev. 165: 105834 (2024). (pdf) |
| 2021 | Renganathan S, Pramanik S, Ekambaram R, Kutzner A, Kim PS, Heese K. Identification of a Chemotherapeutic Lead Molecule for the Potential Disruption of the FAM72A-UNG2 Interaction to Interfere with Genome Stability – Centromere Formation – and Genome Editing. Cancers (Basel) 13(22): 5870 (2021). (IF ~ 5.2) (pdf) |
| 2021 | Ho NTT, Rahane CS, Pramanik S, Kim PS, Kutzner A, Heese K. FAM72 – Glioblastoma Multiform (GBM) and Beyond. Cancers (Basel) 13(5): 1025 (2021). (IF ~ 5.2) (pdf) |
| 2019 | Ho NTT, Kutzner A, Heese K. A Novel Divergent Gene Transcription Paradigm – The Decisive, Brain-Specific, Neural |-Srgap2–Fam72a-| Master Gene Paradigm. Molecular Neurobiology: 56(8): 5891-5899 (2019). (IF ~ 5.1) (pdf) |
| 2019 | Schmidt M, Heese K, Kutzner A. Accurate high throughput alignment via line sweep-based seed processing. Nature Communications 10: 1939 (2019). (IF ~ 16.6) (pdf) |
| 2018 | Sulistio YA, Lee HK, Jung SJ, Heese K. Interleukin-6-Mediated Induced Pluripotent Stem Cell (iPSC)-Derived Neural Differentiation. Molecular Neurobiology 55(4): 3513-3522 (2018). (IF ~ 5.1) (pdf) |
| 2017 | Pramanik S, Sulistio YA, Heese K. Neurotrophin signaling and stem cells – implications for neurodegenerative diseases and stem cell therapy. Molecular Neurobiology 54(9): 7401-7459 (2017). (IF ~ 5.1) (pdf) |
| 2017 | Ho NTT, Kutzner A, Heese K. Brain plasticity, cognitive functions and neural stem cells: a pivotal role for the brain-specific neural master gene |-SRGAP2–FAM72-|. Biological Chemistry 399(1): 55-61 (2017). (IF ~ 3.7) (pdf) |
| 2017 | Ho NTT, Kim PS, Kutzner A, Heese K. Cognitive Functions: Human vs. Animal – 4:1 Advantage |-FAM72–SRGAP2-|. Journal of Molecular Neuroscience 61: 603-606 (2017). (IF ~ 3.1) (pdf) |
| 2016 | Sulistio YA, Heese K. The ubiquitin proteasome system and molecular chaperone deregulation in Alzheimer's disease. Molecular Neurobiology 53(2): 905-931 (2016). (IF ~ 5.1) (pdf) |
| 2013 | Manavalan A, Mishra M, Feng L, Sze SK, Akatsu H, Heese K. Brain site-specific proteome changes in aging-related dementia. Experimental & Molecular Medicine 45: e39 (2013). (IF ~ 12.8) (pdf) |
| 2013 | Heese K. G proteins, p60TRP, and neurodegenerative diseases. Molecular Neurobiology 2013 47(3): 1103-1111. (IF ~ 6.0) (pdf) |
| 2011 | Mishra M, Heese K. P60TRP interferes with the GPCR/secretase pathway to mediate neuronal survival and synaptogenesis. J. Cell. Mol. Med. 15(11): 2462-2477 (2011). (IF ~ 5.3) (pdf) |
| 2009 | Islam O, Gong X, Rose-John S, Heese K. Interleukin-6 and neural stem cells more than gliogenesis. Mol. Biol. Cell. 20: 188-199 (2009). (IF ~ 3.3) (pdf) |
| 2007 | Ayyadhury, S., Heese, K. Neurotrophins More Than Neurotrophic. Curr. Immunol. Rev. 3: 189-215 (2007). (pdf) |
| 2006 | Lin T, Islam OM, Heese K. ABC transporters, neural stem cells and neurogenesis–a different perspective. Cell Res. 16(11): 857-871 (2006). (IF ~ 44) (pdf) |
| 2006 | Heese K, Akatsu H. Alzheimer’s Disease – An Interactive Perspective. Curr. Alzheimer Res. 3(2): 109-121 (2006) (incl. Cover page). (IF ~ 2.1) (pdf) |
| 2006 | Heese K, Inoue N, Sawada T. NF-κB regulates B-cell-derived Nerve Growth Factor Expression. Cellular & Molecular Immunology. 3(1): 63-66 (2006). (IF ~ 24.1) (pdf) |
| 2000 | Hock C, Heese K, Hulette C, Rosenberg C, Otten U. Region specific neurotrophin inbalances in Alzheimer’s disease: decreased levels of BDNF and increased levels of NGF in hippocampus and cortical areas. JAMA Neurology 57(6): 846-851 (2000). (IF ~ 29) (pdf) |
| 2000 | Hock C, Heese K, Müller-Spahn F, Huber P, Riesen W, Nitsch RM, Otten U. Increased CSF levels of neurotrophin 3 in elderly patients with major depression. Molecular Psychiatry. 5(5): 510-513 (2000). (IF ~ 11) (pdf) |
| 2000 | Hock C, Heese K, Müller-Spahn F, Huber P, Riesen W, Nitsch RM, Otten U. Increased CSF levels of nerve growth factor in patients with Alzheimer’s disease. Neurology. 54(10): 209-2011 (2000). (IF ~ 10.1) (pdf) |